Clinical trials
Phase 2 COVID-19 trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
174 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 74 |
| 2021 | 51 |
| 2022 | 32 |
| 2023 | 12 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 174 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sinocelltech Ltd. | 7 |
| The University of Hong Kong | 6 |
| Kafrelsheikh University | 4 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| Livzon Pharmaceutical Group Inc. | 3 |
| AB Science | 2 |
| ANRS, Emerging Infectious Diseases | 2 |
| Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2 |
| D'Or Institute for Research and Education | 2 |
| Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 174 |
| Coronavirus Infections | 14 |
| Pneumonia | 8 |
| Respiratory Distress Syndrome | 8 |
| Pneumonia, Viral | 6 |
| Cytokine Release Syndrome | 5 |
| Inflammation | 3 |
| Severe Acute Respiratory Syndrome | 3 |
| Infections | 2 |
| Neoplasms | 2 |
Trials
Showing 1 to 25 of 174. Each trial links to its page on Pharma Observatory.
74 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.